CD8A and non-small cell lung carcinoma: To delve deeper into the characteristics of the TME as it undergoes changes in response to therapy, we performed a re-clustering analysis of CD8+ T cells using publicly available scRNA-seq data from post-treatment patients with NSCLC, as obtained from the dataset GSE176022.